20225 ⎘
Medicinal preparations containing organic active ingredients; Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO)
MELANOGENESIS INHIBITION COMPOSITIONS AND METHODS OF USE THEREOF
#2A pharmaceutical composition for effectively preventing deactivation and enhancing the targeting activity of SN triple-bond compounds, and a method for preparing the same
#3COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#4ENERGY DRINK COMPOSITION
#5COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA AND OTHER CONDITIONS
#6DOWN TITRATION LOADING OF SOTALOL INTRAVENOUSLY
#7SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF
#8CYSTEAMINE FOR THE TREATMENT, MITIGATION AND PREVENTION OF CORONAVIRAL, E.G., SARS-CoV-2, INFECTIONS
#9Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance
#10ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#11MESDOPETAM COMPOSITIONS
#12Methods of Use for Disulfiram and Metabolites Thereof
#13Sulfur-containing Compounds and Compositions Thereof for Delivery of Nucleic Acids
#14MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#15PROCESS FOR MAKING BEVERAGE COMPOSITIONS CONTAINING CRYOGENICALLY PRODUCED CANNABINOID NANOPARTICLES AND COMPOSITIONS MADE THEREBY
#16COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
#17ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME
#18COMPOSITIONS AND METHODS FOR MODULATING CONDITIONS ASSOCIATED WITH ALTERED ATP8B1 FUNCTION
#19PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF
#20USE OF SRE-PTPRZ1 INHIBITOR IN PREPARATION OF DRUG FOR TREATING SQUAMOUS CELL CARCINOMA
#21Autoimmune Disease Modulation Protocol
#22METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS
#23PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF
#24COMPOSITION COMPRISING ANTI-FOLIC ACID AGENT FOR DIFFERENTIATION OF MESENCHYMAL STEM CELL INTO CARTILAGE
#25PHARMACEUTICAL COMPOSITION CONTAINING FRAXETIN FOR PREVENTION OR TREATMENT OF ENDOMETRIOSIS
#26PHARMACEUTICAL PRESERVATION OF CREE ACTIVATION WITH NITARSONE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
#27NOVEL AMYLOID-BETA AGGREGATE DEGRADER AND BRAIN-TARGETING DRUG DELIVERY SYSTEM USING SAME
#28COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDER
#29COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#302-(2-ETHOXY-4-(ETHYLTHIO)-5-METHOXYPHENYL)ETHAN-1-AMINIUM CHLORIDE
#31METHOD FOR TREATING OR PREVENTING DRUG-INDUCED LIVER INJURY WITH PEPTIDE COMPOSITION
#32ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE
#33Cancer Treatment
#34CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMOPATHIES
#35OPHTHALMIC COMPOSITION
#36ERCC1-XPF COMPLEX INHIBITOR COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER
#37METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL HYDROCHLORIDE FOR THE TREATMENT OF PEDIATRIC PATIENTS
#38TREATMENT OF CANCER WITH S1P RECEPTOR AGONISTS
#39COMPOSITIONS AND METHODS FOR MINIMIZING EFFECTS OF ALCOHOL INTOXICATION
#40Use of Thiol Compounds to Treat Neurological Disease
#41GPR120 AGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
#42ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#43AMINOTHIOL-CONJUGATES, COMPOSITIONS, AND METHODS OF USE THEREOF
#44Controlled Release Of A Hydrophilic Agent From A Coated Surface
#45SLEEP DISORDER TREATMENT AND PREVENTION
#46PATHWAY MODULATOR, PHARMACEUTICAL COMPOSITION HAVING SAME, USE THEREOF, AND THERAPEUTIC METHOD USING SAME
#47COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF
#48COMPOSITIONS OF TAURINE AND MALIC ACID AND METHODS OF MAKING THE COMPOSITIONS
#49COMPOSITIONS OF TAURINE AND MALIC ACID AND METHODS OF MAKING THE COMPOSITIONS
#50COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER
#51BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
#52COMPOSITIONS COMPRISING MIXTURES OF COMPOUNDS AND USES THEREOF
#53IDENTIFICATION OF ACTIVITIES OF GUT MICROBE METABOLITES
#54COMPOSITIONS AND METHODS FOR PROMOTING DEVELOPMENT OF INFANT
#55HALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF
#56METHODS OF TREATING OR PREVENTING PRETERM LABOR
#57INHIBITION OF MAST CELL TUMOR NECROSIS FACTOR FOR THERAPEUTIC USE
#58METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING STRESS-RELATED DISORDER
#59METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#60PERSONALIZED MODULATION THERAPY FOR CANCER
#61COMBINATORIAL THERAPEUTIC APPROACH FOR FRIEDREICH'S ATAXIA
#62NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USING THE SAME
#63METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REPAIRING INTESTINAL MUCOSAL
#64AN OPHTHALMIC FORMULATION FOR TREATMENT AND PREVENTION OF CATARACT AND PRODUCTION METHOD THEREOF
#65C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN
#66TREATMENT OF ACUTE TISSUE INJURY
#67COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF VASCULAR MALFORMATIONS
#68GASDERMIN-D INHIBITORS AND USES THEREOF FOR TREATING PULMONARY VASO-OCCLUSION
#69CLASS OF ALKYLPHENOL COMPOUNDS AND PREPARATION METHOD THEREFOR
#70COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS
#71COMPOSITION, FORMULATION, PREPARATION METHOD AND USE FOR GLUTATHIONE PRECURSOR
#72METHODS FOR THE TREATMENT OF CANCER
#73SUBSTITUTED PHENETHYLAMINE FOR TREATING INFLAMMATION AND PSYCHOLOGICAL DISORDERS
#74METHODS OF USING COMPOUND OF GLYCOSAMINOGLYCAN
#75USES OF GLYCOSAMINOGLYCAN CONJUGATES
#76LIPOSOME ENCAPSULATING CYSTEAMINE AND RESVERATROL IN SEPARATE COMPARTMENTS
#77APOL1 INHIBITORS AND METHODS OF USE
#78COMPOSITIONS AND METHODS FOR IMPROVING EYE FUNCTION
#79ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF
#80COMPOSITIONS COMPRISING ORGANIC MINERAL CHELATES, NIACINAMIDE, AND HEMP OIL AND USES THEREOF FOR NEUROPROTECTION, CARDIOPROTECTION, DETOXIFICATION, IMMUNE SUPPORT, AND ANTI-AGING
#81Cancer treatment
#82COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC NEUROPATHIES
#83ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#84SUPPRESSION OF COVID-19 REPLICATION BY COVID-19 ENTRY INHIBITORS
#85Acyclic Thiol Prodrugs
#86NOVEL SQUARAMIDE DERIVATIVE AND USE THEREOF
#87METHOD TO SCREEN COMPOUNDS FOR ANTIFUNGAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO TREAT FUNGAL DISEASES BY INHIBITING SPORE GERMINATION
#88METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER
#89ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE
#90INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF
#91COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDER
#92IMIDAZO[1,2-B]PYRIDAZINE BASED TRICYCLIC COMPOUNDS AS INHIBITORS OF HASPIN AND THERAPEUTIC USES THEREOF
#93Targeted Therapeutic Lipid Nanoparticles and Methods of Use
#94COMPOUNDS THAT SYNERGIZE WITH COPPER TO KILL STREPTOCOCCUS PNEUMONIAE
#95PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME
#96POWDER COMPOSITION FOR DISINFECTION OF THE TEATS OF DAIRY ANIMALS
#97SUSTAINED RELEASE INJECTABLE THERAPEUTIC FORMULATIONS USING APROTIC POLAR SOLVENTS
#98TREATMENT FOR AORTOPATHY
#99METHODS FOR IMPROVED DELIVERY OF AMINOTHIOLS, DIMERS OF AMINOTHIOLS, AND HETERODIMERS COMPOSED OF AMINOTHIOLS
#100COMPOSITIONS AND METHODS FOR PREVENTING AND PROTECTING AGAINST DAMAGE IN CELLS AND TISSUES
#101COMPOSITIONS AND METHODS FOR TREATING OCULAR CHEMICAL BURNS
#102USE OF N-ACETYLCYSTEINE TO TREAT CNS DISORDERS
#103COMBINATION THERAPY WITH MEK INHIBITOR AND CDK4/6 INHIBITOR TO TREAT PANCREATIC CANCER
#104METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#105Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomopathies
#106MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#107METHOD OF TREATING A PERSON AFFLICTED WITH A RESPIRATORY CONDITION AND PHARMACEUTICAL FORMULATION INCLUDING DAPSONE
#108USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES
#109ATHLETIC PERFORMANCE ENHANCEMENT COMPOSITION USING MENTHOL
#110DRUGS, THERAPEUTIC COMBINATIONS AND METHODS FOR PREVENTING VIRAL AND MICROBIAL INFECTIONS AND THEIR SEQUELAE
#111ANTIVIRAL SUPPLEMENT FORMULATIONS
#112METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#113COMPOSITION FOR TREATING AND/OR PREVENTING A HANGOVER
#114ANTI-CANCER COMPOSITION CONTAINING AURANOFIN AND MERCAPTO COMPOUND AND USE THEREOF
#115Combination drug products for treating patients suffering from one or more medical conditions caused by coronavirus infection, including by SARS-CoV-2, its alpha, beta, delta, or omicron variants and sub variants
#116Cystamine Formulations and Uses Thereof
#117Nucleic Acid-Derivatized Therapeutics
#118CHEMICAL MODIFICATIONS FOR INHIBITING EXPRESSION OF ALDH2
#119Use of N-acetylcysteine to treat central nervous system disorders
#120GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
#121COMPOSITIONS, METHODS OF TREATMENT, AND CONTAINERS INCLUDING COMPOSITIONS
#122Bag System Containing a Nutrient Composition Comprising Whole Food Sole Source Meal
#123Methods for improved protection and delivery of aminothiols and analogs thereof
#124DIETARY SUPPLEMENT COMPOSITION COMPRISING COLLAGEN
#125Spirolactone compounds
#126TREATMENT OF FUNGAL NAIL INFECTION
#127ANTI-VIRAL THERAPY
#128ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#129METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE
#130DISINFECTING, SKIN-TOLERABLE CARE AGENT FOR APPLICATION TO THE SKIN
#131Sleep disorder treatment and prevention
#132APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCE
#133METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE
#134MICROBIAL THERAPY
#135Compositions comprising mixtures of compounds and uses thereof
#136DOFETILIDE DRUG DOSING METHODS AND SYSTEMS AND PRESCRIPTION DRUG USE RELATED SOFTWARE
#137Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
#138IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
#139PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM
#140SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT
#141Combinations of β-lactam compounds and probenecid and uses thereof
#142Methods for continuous manufacture of liposomal drug products
#143Acyclic thiol prodrugs
#144COMPOSITIONS AND METHODS OF TREATMENT WITH GLUTATHIONE
#145METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS
#146USE OF NOREPINEPHRINE OR BETA-ADRENERGIC RECEPTOR INHIBITOR IN PREPARATION OF MEDICAMENT FOR NERVE INJURY REPAIR IN DIABETES
#147METHODS AND NUTRACEUTICAL COMPOSITIONS FOR THE PREVENTION AND/OR MITIGATION OF VEISALGIA
#148RADIO-AND CHEMO-PROTECTIVE COMPOUNDS
#149COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS PRODUCTION OF HYDROGEN SULFIDE (H2S)
#150THIOL-CONTAINING COMPOUNDS FOR USE IN TREATING CORONAVIRUS
#151Compositions and methods for the treatment and prevention of vascular malformations
#152COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#153METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS
#154Use of thiol compounds to treat neurological disease
#155DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF FOR FAT LOSS
#156ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#157ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE
#158COMPOSITION AND METHOD FOR MODULATING HYDROGEN ION PHYSIOLOGY RELATED TO BRAIN HEALTH COMPONENT
#159COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION
#160Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
#161Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability
#162Method of treatment of topical dermatologic acne using a cream composition and method of manufacture
#163COMPOSITION
#164Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone
#165CHEMOTHERAPEUTIC DRUG IMPLANT
#166METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#167Dosage form for use in treating or preventing of a disease
#168FREEZE-DRIED POWDER CONTAINING 2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGEL
#169ACELLULAR PLACENTAL THERAPIES FOR NECROTIZING ENTEROCOLITIS
#170MODULATING RESISTANCE TO BCL-2 INHIBITORS
#171THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE
#172EP2 ANTAGONIST
#173ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#174Compositions comprising mixtures of compounds and uses thereof
#175ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH
#176COMPOUNDS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#177Composition for protecting liver, protecting intestines and enhancing immunity for freshwater fish, and preparation and application thereof
#178Compositions, methods of treatment, and containers including compositions
#179Antiviral supplement formulations
#180AGENT FOR TREATING, PREVENTING OR IMPROVING PSYCHIATRIC AND NERVOUS SYSTEM DISORDERS OR SYMPTOMS
#181PARAXANTHINE-BASED COMPOSITIONS FOR PROMOTING WEIGHT LOSS
#182METHODS FOR IMPROVED DELIVERY OF AMINOTHIOLS, DIMERS OF AMINOTHIOLS, AND HETERODIMERS COMPOSED OF AMINOTHIOLS
#183USE OF AN OSMOLYTE IN MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF OCULAR DISORDERS
#184METHODS AND COMPOSITION FOR TREATING RESPIRATORY OBSTRUCTIVE DISEASES
#185USE OF DISULFIRAM OR ITS DERIVATIVES FOR THE TREATMENT OF MITOCHONDRIAL DISEASES OR DYSFUNCTION
#186Nutrition blend for health benefits in animals
#187Methods for the treatment of infections
#188Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
#189MEDICAL AND NUTRITIONAL COMPOSITIONS AND METHODS OF USE
#190Homotaurine-enriched compositions and methods of use for animal health
#191TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
#192METHODS OF TREATING OR PREVENTING PRETERM LABOR
#193COMPOSITION COMPRISING L-CARNITINE FOR THE TREATMENT OF MALE INFERTILITY
#194Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
#195Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose
#196Uses of glycosaminoglycan conjugates
#197SOLID NUTRIENT COMPOSITIONS AND ASSOCIATED METHODS
#198Methods of treating IgA nephropathy with thiol-containing molecules
#199METHODS FOR TREATING DILATED CARDIOMYOPATHY
#200COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA AND OTHER CONDITIONS
#201ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME
#202Use of System XC-Inhibitor for Treating Statin-Induced Myalgia
#203Combination therapies with disulfiram
#204COMBINATION THERAPIES WITH DISULFIRAM
#205Inhibitors of SARM1 NADase activity and uses thereof
#206Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
#207ADO-resistant cysteamine analogs and uses thereof
#208Edible Energy Composition
#209METHODS FOR THE TREATMENT OF MYCOBACTERIUM INFECTIONS
#210USE OF DISULFIRAM AND OTHER COMPOUNDS TO TREAT CANCERS WITH LOSS OF CHROMOSOME 16Q AND/OR LOW EXPRESSION OF METALLOTHIONEIN PROTEINS
#211Compound and Composition for Use in the Preventive and/or Curative Treatment of Diseases of the Central Nervous System Characterised by a Decline in Neuronal Plasticity, in Particular Characterised by a Decline in Synaptic Plasticity
#212COMPOSITION AND METHOD FOR TREATING THE LUNGS
#213DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#214Compositions and methods for treatment of diabetic neuropathies
#215Combination treatments for opioid crisis
#216Cysteamine for the Treatment, Mitigation and Prevention of Coronaviral, e.g., SARS-CoV-2, Infections
#217Bisphenol derivatives and their use as androgen receptor activity modulators
#218Oligosaccharide as therapeutic agent for alcohol associated liver disease
#219Use Of Disulfiram For Treating Infection Of SARS-COV-2
#220DOSAGE REGIME
#221METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#222TREATMENT OF CYSTINOSIS
#223SMALL MOLECULE ACTIVATORS OF POLYCYSTIN-2 (PKD2) AND USES THEREOF
#224Synergistic nutritional compositions for treating seizures and chronic inflammatory diseases
#225THERMORESPONSIVE GEL EYE DROP FOR OCULAR DELIVERY OF CYSTEAMINE
#226CYSTEAMINE ZINC COMPLEX AND METHOD OF USING A CYSTEAMINE ZINC COMPLEX
#227Use of VNN1 as a biomarker and a therapeutic target in sarcomas
#228SEMI-SOLID CAFFEINATED COMPOSITION AND METHODS OF MAKING AND USING THEREOF
#229Athletic performance enhancement composition using menthol
#230COMBINATION THERAPIES FOR TREATMENT OF INFLAMMATORY DISEASES
#231Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof
#232Dapsone formulations and methods of using same
#233Use of CFTR Modulators For Treating Cerebrovascular Conditions
#234Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia
#235NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USING THE SAME
#236Administering compositions for improved immune system functioning
#237Aminothiol reduction of ischemia-reperfusion-induced cell death
#238METHOD TO PREVENT AND TREAT OCULAR CATARACT BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#239COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER
#240Use of cysteamine and derivatives thereof to suppress tumor metastases
#241Constituent combination for treating stress
#242METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#243INTRAVENOUS SOTALOL HYDROCHLORIDE LOADING AND MAINTENANCE FOR CARDIAC SURGERY PATIENTS
#244Compositions and methods for treatment of mitochondrial respiratory chain dysfunction and other mitochondrial disorders
#245Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
#246METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION
#247Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#248Salt of cysteamine for the preparation of highly respirable particles
#249COMPOSITIONS COMPRISING ORGANIC MINERAL CHELATES, NIACINAMIDE, AND HEMP OIL AND USES THEREOF FOR NEUROPROTECTION, CARDIOPROTECTION, DETOXIFICATION, IMMUNE SUPPORT, AND ANTI-AGING
#250Modulators of Sestrin-GATOR2 interaction and uses thereof
#251Compounds and methods for inhibiting CPY26 enzymes
#252ANALGESIC AGENT AND SEDATIVE AGENT
#253Targeting PAX2 for the treatment of breast cancer
#254Combination therapy with MEK inhibitor and CDK4/6 inhibitor to treat pancreatic cancer
#255TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
#256Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability
#257TARGETED DELIVERY OF HYDROPHILIC DRUGS TO LUNG
#258Controlled release of a hydrophilic agent from a coated surface
#259Methods for cancer therapy
#260Administration of serine protease inhibitors to the stomach
#261Combination treatments for opioid crisis
#262Spirolactone compounds
#263METHODS OF TREATING MINIMAL RESIDUAL CANCER
#264METHODS AND MATERIALS FOR ASSESSING AND TREATING LICHEN PLANUS
#265Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
#266Methods of Treating Excitotoxicity Disorders
#267Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)
#268Food, cosmetic and pharmaceutical formulation with an immunomodulatory and protective anti-viral effect
#269Edible Energy Composition
#270ZINC ASSOCIATED TREATMENT FOR AND DIAGNOSIS OF CACHEXIA
#271Use of Thiol Compounds to Treat Neurological Disease
#272METHODS FOR PREVENTION AND TREATMENT OF UROGENITAL ATROPHY OF MENOPAUSE BY CONTACT VASODILATORS
#273METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER
#274Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#275Methods for improved protection and delivery of aminothiols and analogs thereof
#276Use of isothiocyanate functional surfactants as NRF2 inducers to treat epidermolysis bullosa simplex and related diseases
#277METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#278Methods for continuous manufacture of liposomal drug products
#279NOVEL APPLICATIONS OF DISULFIRAM AND DERIVATIVES THEREOF
#280METHODS FOR TREATING INFLAMMATORY DISEASES
#281METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#282METHODS FOR THE TREATMENT OF INFECTION
#283DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS
#284C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
#285Compositions and methods for treating peripheral nerve disease, disorders, and injuries
#286METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE
#287Use of N-acetylcysteine to treat central nervous system disorders
#288Composition of heat-killed yeast and taurine or a phytomedicine for the treatment of chronic inflammation
#289METHOD FOR PROMOTING LIPID METABOLISM OR ASSISTING IN BODY WEIGHT CONTROL
#290Sleep disorder treatment and prevention
#291Enterically coated cysteamine, cystamine and derivatives thereof
#292NON-TOXIC TOPICAL FORMULATIONS OF DAPSONE
#293Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#294Bisphenol derivatives and their use as androgen receptor activity modulators
#295BENIGN PROSTATIC HYPERPLASIA ADD-ON THERAPY
#296Tetrahydrocurcumin compositions, methods of making, and methods of using the same
#297ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE
#298Methods for the treatment of cysteamine sensitive disorders
#299Methods for storing cysteamine formulations and related methods of treatment
#300Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid